Brucellosis is a zoonotic infectious disease caused by Brucella species, still endemic in our country affecting different organs and systems. 
Brucella species microorganisms were isolated in the blood cultures. The patients were successfully treated with doxycicline (2 x 100mg) and rifampicin (1 X 600mg).
As a result, we would like to remind that brucellosis might be transmited in the laboratory environment and in order to prevent the contamination the personnel must comply with the use of protective equipment. As
for the clinicians, they should consider investigating brucellosis in laboratory personel presenting with fever. (Table 1) (6).
Brucellosis is still endemic in our country and the annual incidence of the disease is 23 per 100,000 (7).
Therefore, the laboratory personnel working with these bacteria are under the risk of contamination.
However, laboratory acquired brucellosis cases are rarely reported in our country (8) (9) (10) (11) . In a multicenter Table 1 . It should also be kept in mind that antibiotic side effects may occur. Related lethal side effects have also been reported (16) . Therefore, risk classification should be performed and antibiotic prophylaxis should not be given unless required. PEP should be offered as soon as Brucella exposure has been identified, up to the end of the 6-month incubation period.
* Administer doxycycline 100 mg twice daily and rifampin 600 mg once daily for 3 weeks or doxycycline
*
Trimethoprim-sulfamethoxazole (160 mg/800 mg) should be considered for patients with contraindications to doxycycline.
* Pregnant workers with high-risk exposures should be considered for PEP in consultation with their obstetricians.
A low-risk exposure is defined as being present in the laboratory during an exposure but not meeting the definition for a high-risk exposure.
Discuss potential PEP with workers who have low-risk exposures to Brucella isolates. * Obtain baseline serum samples from all workers exposed to Brucella sp.
* Arrange for serologic testing on all workers exposed to Brucella sp. (eg, 2, 4, 6, and 24 weeks postexposure) using agglutination testing (eg, tube or Brucella microagglutination testing) * Arrange for regular (eg, weekly) active surveillance for febrile illness among all workers exposed to Brucella isolates for 6 months after last exposure.
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In conclusion, it is very important to educate the healthcare personnel working in the presence of Brucella species of the transmission pathways, to provide the use of protective equipment and biosafety cabinets, and to increase the compliance with infection control measures in order to prevent laboratory acquired brucellosis in endemic countries such as ours. In case of contact, risk classification should be performed and antibiotic prophylaxis started. Beside this, it is also important for clinicians to evaluate those admitted with such complaints as high fever, and muscular and joint pains for brucellosis in terms of earlier diagnosis, and prevention of possible complications.
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